UniProtKB/Swiss-Prot Q02742 : Variant p.Ile152Val
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase
Gene: GCNT1
Feedback ?
Variant information
Variant position:
152
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LB/B
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Isoleucine (I) to Valine (V) at position 152 (I152V, p.Ile152Val).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
152
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
428
The length of the canonical sequence.
Location on the sequence:
KIEMLDRLLRAIYMPQNFYC
I HVDTKSEDSYLAAVMGIASC
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KIEMLDRLLRAIYMPQNFYCI HVDTKSEDSYLAAVMGIASC
Mouse KIEMLDRLLRAIYMPQNFYCI HVDRKAEESFLAAVQGIASC
Bovine KIEMLDRLLRAIYMPQNFYCI HVDAKSEKSFLAAAVGIASC
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 428
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase
Topological domain
33 – 428
Lumenal
Region
122 – 428
Catalytic
Disulfide bond
59 – 413
Disulfide bond
100 – 172
Disulfide bond
151 – 199
Literature citations
Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen.
Bierhuizen M.F.A.; Fukuda M.;
Proc. Natl. Acad. Sci. U.S.A. 89:9326-9330(1992)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT VAL-152; FUNCTION; CATALYTIC ACTIVITY; PATHWAY;
Genomic organization of core 2 and I branching beta-1,6-N-acetylglucosaminyltransferases. Implication for evolution of the beta-1,6-N-acetylglucosaminyltransferase gene family.
Bierhuizen M.F.A.; Maemura K.; Kudo S.; Fukuda M.;
Glycobiology 5:417-425(1995)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT VAL-152;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.